Carisma Therapeutics to get $80M in cash and investment through new deal with Moderna
January 10, 2022 at 12:16 PM EST
Moderna will make a $45 million upfront payment and invest another $35 million in the Penn spinout.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|